Name: ImageneBio, Inc. (IMA) Cash Flow Statement
Creator: FinSpry

ImageneBio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for ImageneBio, Inc. (IMA) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Operating Activities
Net Income	-49.23	-21.15	-68.77	-34.12
Depreciation & Amortization	0.49	3.10	0.80	0.54
Stock Based Compensation	5.30	0.00	0.00	0.00
Change in Working Capital	-3.98	0.90	-15.14	-33.03
Change in Accounts Payable	-1.17	3.89	0.00	0.00
Change in Other Working Capital	-2.81	-0.94	0.00	0.00
Other Operating Activities	1.42	-0.94	7.53	5.18
Net Cash from Operating Activities	-46.00	-18.23	-74.11	-60.25
Investing Activities
Capital Expenditures	0.00	-0.31	1.43	1.76
Purchases of Investments	-88.30	-20.15	0.00	0.00
Sales/Maturities of Investments	60.46	10.00	-97.85	0.00
Other Investing Activities	-7.07	0.00	0.00	0.00
Net Cash from Investing Activities	-34.90	-10.45	-99.28	-1.76
Financing Activities
Common Stock Issued	0.00	0.15	0.00	131.30
Other Financing Activities	0.00	76.51	0.00	131.30
Net Cash from Financing Activities	0.00	0.15	1.10	131.74
Summary
Effect of Forex Changes on Cash	0.00	-0.15	0.00	0.00
Net Change in Cash	-80.91	-28.54	-172.30	69.73
Cash at Beginning of Period	121.17	44.01	233.09	163.36
Cash at End of Period	40.27	15.32	60.79	233.09
Free Cash Flow	-46.00	-18.54	-75.54	-62.01
Supplemental Disclosures
Income Taxes Paid	0.22	0.12	0.00	0.00